humana glp 1 coverage Medicare obesity drug GLP-1 starting July Humana's CenterWell Expands Specialty Pharmacy

Korytkowski M

"Suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case-time-control study." eClinicalMedicine 80 (2025): 103029

In the following section, we will explore the impact of activating GLP-1 signaling on various aging hallmarks, with the aim of potentially extending both lifespan and healthspan, as well as gaining insights into how the modulation of GLP-1R signaling may affect aging at both cellular and systemic levels

Health plans may steer a drug into the pharmacy benefit to leverage rebates, or into the medical benefit to take advantage of site-of-care differences

government recently struck deals with the makers of tirzepatide and semaglutide (Eli Lilly and Novo Nordisk) to cut costs, potentially making the medications available for less than $350 a month in the future.